Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT04060056
Active, not recruiting Not applicable

Westlake Precision Birth Cohort

NCT04060056 · tracked via the Priya Life Science China tracker
Sponsor
Westlake University
Phase
Not applicable
Started
2019-08-30
Last updated
2026-09-25

Condition(s) studied

Diabetes, GestationalPregnancy in DiabeticsIntrauterine Hyperglycemia

Investigational drug(s) / intervention(s)

Standardized breakfastStandardized snackStandardized lunch

Standardized breakfast: Participants will be provided with a standardized breakfast on a morning of the days they wear a continuous glucose monitoring (CGM) device.

Standardized snack: Participants will be provided with a standardized snack 2 hour after they have the standardized breakfast.

Standardized lunch: Participants will be provided with a standardized lunch 2 h after they have the standardized snack.

Study summary

The Westlake Precision Birth Cohort (WeBirth) is a prospective cohort study among women with hyperglycemia during pregnancy and their offspring living in Hangzhou, China. The primary aim of this cohort is to characterize the continuous blood glucose response to dietary intake and physical activity among pregnant women with gestational diabetes mellitus (GDM) over 2 weeks, and to facilitate the development of personalized nutritional/lifestyle recommendation among these patients. Another aim of WeBirth is to investigate the association of dietary intake and physical activity together with continuous glucose change during pregnancy on the adverse birth outcomes including preterm birth, macrosomia and large-for-gestational-age birth. The secondary aim is to investigate the prospective associations of diet, physical activity and continuous glucose change over 2 weeks among the participants with long-term metabolic health of these women and their offspring.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Women aged 18 years or older * Women with GDM at 24-28 weeks of gestation * Women intended to deliver at Hangzhou Women's Hospital * Women intended to remain in Hangzhou with their child for ≥4 years Exclusion Criteria: ● Women with cancer and other serious medical disorders

Primary outcome measure(s)

  • Continuous blood glucose change over 2 weeks — Two weeks after enrollment
    Glucose levels are assessed by continuous glucose monitoring over 2 weeks.
  • Adverse birth outcomes — 9-12 weeks after enrollment
    Number of participants with adverse birth outcomes, such as, preterm birth, macrosomia and neonatal hypoglycemia.

Trial sites (1)

FacilityCityRegionStatus
Hangzhou Women's Hospital Hangzhou Zhejiang

More Westlake University trials in China

Study of Clostridioides Difficile in Infants Recruiting
Westlake Longevity Cohort Recruiting
Skin Microbiome of Chinese Population Cohort Study Active, not recruiting
Westlake Frequent-sampling Cohort 2 Active, not recruiting
Dynamic Monitoring of Urinary Electrolytes Active, not recruiting

Other trials for the same condition

The Born in Guangzhou Cohort Study (BIGCS) Recruiting
Wenzhou Gestational Diabetes Cohort Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04060056 on ClinicalTrials.gov ↗ ← All trials in China